Generally, carriers of BRCA1 and BRCA2 mutations have an increased risk (71.4-87% for the BRCA1 mutation and 77-88% for the BRCA2 mutation) of developing breast and ovarian cancers [6]. The gene discussed is BRCA2; the disease is ovarian carcinoma.